fda changes to tirzepatide FDA's Removal of Semaglutide and the Evolving Decisions: What Compounders Need Know F.D.A. Approves New Obesity Drug

Andrew Sargent, Michael Leszko, Noelle N

[DOI] [PubMed] [Google Scholar] 174.Gothe S

When semaglutide rapidly lowers your glucose levels, the lens can briefly swell or change shape, and the result is blurry or fluctuating vision

And Sodhi noted, "the number just continues to climb when you blow it up to the population level." "When you have more than a million people taking the medication worldwide, that's 10,000 people who could potentially experience gastroparesis according to the incidence rate for semaglutide," he told CNBC

To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter